Abstract
This Frost & Sullivan research service titled European Autoimmune Disease
Therapeutics Market provides an overview of current treatment options, drugs
in pipeline and technological advancements in the market. It also a complete
analysis of key market drivers, restraints and revenues involved in the
current rheumatoid arthritis and multiple sclerosis medications. In this
research, Frost & Sullivan' s expert analysts thoroughly examine the following
therapeutics markets for rheumatoid arthritis and multiple sclerosis.
This research service is available through our Pharmaceutical & Biotechnology
Growth Partnership Services program. With this program you receive
industry-leading market research such as this, along with technical and
econometric data and many interactive features including Analyst Inquiry Time
and Client Councils.
Table of Contents
1 EXECUTIVE SUMMARY
2 RESEARCH METHODOLOGY
3 MARKET OVERVIEW
4 INDUSTRY CHALLENGES
- Industry Challenges
- Major Industry Challenges
5 MARKET ENGINEERING RESEARCH FOR MULTIPLE SCLEROSIS MARKET
- Multiple Sclerosis Market
- Disease State Overview
- Market Engineering Measurements
- Market Drivers
- Market Restraints
- Competitive Structure
- Brand Analysis
- Revenue Forecasts
6 MARKET ENGINEERING RESEARCH FOR RHEUMATOID ARTHRITIS MARKET
- Rheumatoid Arthritis Market
- Disease State Overview
- Market Engineering Measurements
- Market Drivers
- Market Restraints
- Competitive Structure
- Brand Analysis
- Revenue Forecasts
7 STRATEGIC RECOMMENDATIONS
- Market Engineering Recommendations
- Strategic Recommendations
8 DATABASE OF KEY INDUSTRY PARTICIPANTS
- Key Industry Participants
9 APPENDIX
- Decision Support Database Tables
- Multiple Sclerosis Prevalence
- Multiple Sclerosis Mortality
- Arthritis Prevalence
- Male Population 65 and Above
- Female Population 65 and Above
| 
